Owlet infant monitoring sock pulled following FDA warning
After receiving a warning letter from the U.S. Food and Drug Administration, Utah-based tech startup Owlet, innovators of a baby sock that monitors infant vital signs, will stop selling the product until it earns approval from the FDA.
Source: deseret.com